Costa Mesa-based ICN Pharmaceuticals, which develops, manufactures...

Costa Mesa-based ICN Pharmaceuticals, which develops, manufactures and sells pharmaceutical products and services primarily in the United States, Canada, Mexico and Europe, reported that revenue for the year ended Nov. 30, 1986, increased 64% over the same period in 1985. Income from operations rose 314%. ICN has been testing Virazole--also known as ribavirin--on more than 350 patients at medical centers across the United States. The clinical trials are a prerequisite to applying for Food and Drug Administration approval to market Virazole as an AIDS treatment.